News

Dr Ronald Pies questions the statements in regards to antidepressant response time from an October 2005 article in Psychiatric Times.

Colin T. McDonald, MD, specialized in neuro-critical care at Massachusetts General Hospital (Mass General), Harvard Medical School in Boston in 1998, when the father of an emergency room physician at an affiliated hospital became one of his patients. One morning, the father experienced symptoms of stroke, which the son immediately recognized. Doing something about those symptoms, however, was complicated; the father and son were on Martha's Vineyard, where the local hospital was not equipped for emergency neurology care.

Neurotechnologic devices are proving themselves in clinical medicine. Many of these devices offer several distinct advantages over traditional pharmaceutical-based therapies: their effects are reversible, they are often cheaper than pharmaceuticals, and they solve therapy adherence issues. "If a problem occurs, you can turn off the device; or if the disease evolves over time, you can dynamically adjust the device," explained Ali R. Rezai, MD, chairman of the Center for Neurological Restoration at the Cleveland Clinic.